A Study of the Safety and Efficacy of AGN-214868 in Patients With Postherpetic Neuralgia

Clinical trial NCT01129531 · COMPLETED

Trial details

NCT number: NCT01129531
Sponsor: Allergan
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Neuralgia, Postherpetic

Start date: 2010-06-01
Primary completion: 2011-10-01
Enrollment: 294

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.